PolyMedix, Inc. (OTCBB:PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and life-threatening infectious diseases, was named the winner of Philadelphia Business Journal’s Best Mid-Stage Product Development Company award.
